Assuntos
Doenças do Sistema Nervoso Central/diagnóstico , Doenças do Sistema Nervoso Central/etiologia , Terapia de Imunossupressão/efeitos adversos , Transplante de Rim/efeitos adversos , Transtornos Linfoproliferativos/diagnóstico , Transtornos Linfoproliferativos/etiologia , Idoso , Diagnóstico Diferencial , Eletroencefalografia , Feminino , Humanos , Imageamento por Ressonância MagnéticaRESUMO
KEY CLINICAL MESSAGE: Acute myeloid leukemia (AML) with t(8:16) is an infrequent acute leukemia subtype. It can occur de novo or more frequently therapy-related. The presence of blasts with monocytoid morphology and erythrophagocytosis suggest the presence of the t(8;16).
RESUMO
INTRODUCTION: The association between anaphylactic reactions and systemic mastocytosis is well documented. However, platelet transfusion has not previously been reported as a potential elicitor of anaphylaxis in the context of systemic mastocytosis. CASE PRESENTATION: We describe the clinicopathological findings of a 59-year-old Latin American man who presented to the emergency room with fatigue, leukocytosis, thrombocytopenia and mild hepatosplenomegaly. He developed two separate, temporally associated and severe anaphylactic reactions after receiving platelet transfusions. The result of a laboratory investigation for clerical errors and Coombs test was negative. Pre- and post-transfusion urine samples were negative for hemolysis. Bone marrow biopsy and aspirate smears performed demonstrated involvement by systemic mastocytosis, which had been previously undiagnosed. CONCLUSIONS: We posit the transfusion reaction to be an anaphylactic reaction to transfused products as a result of heightened allergic sensitivity due to the underlying systemic mastocytosis. To the best of our knowledge, this is the first reported case of a severe anaphylactic-type reaction to blood products occurring in the setting of a previously undiagnosed systemic mastocytosis. Furthermore, it seems there are no published studies closely examining the relationship between hematopoietic neoplasms and transfusion reactions in general.
Assuntos
Anafilaxia/etiologia , Mastocitose Sistêmica/diagnóstico , Transfusão de Plaquetas/efeitos adversos , Medula Óssea/patologia , Evolução Fatal , Humanos , Masculino , Mastocitose Sistêmica/complicações , Mastocitose Sistêmica/patologia , Pessoa de Meia-IdadeAssuntos
Anticorpos Monoclonais Murinos/efeitos adversos , Linfócitos B/efeitos dos fármacos , Células Dendríticas Foliculares/efeitos dos fármacos , Imunofenotipagem , Linfonodos/efeitos dos fármacos , Antineoplásicos/efeitos adversos , Linfócitos B/imunologia , Células Dendríticas Foliculares/imunologia , Humanos , Imunofenotipagem/métodos , Linfonodos/imunologia , Linfonodos/patologia , Linfocele/diagnóstico , Linfocele/imunologia , Masculino , Pessoa de Meia-Idade , Rituximab , Resultado do TratamentoRESUMO
Anaplastic lymphoma kinase (ALK)-positive diffuse large B-cell lymphoma (DLBCL) is a recently described, uncommon form of DLBCL, which has been seen primarily in young men and which presents with advanced disease. The fact that ALK-positive DLBCL is an uncommon diagnosis is likely due to the combined effects of this being an uncommon disease coupled with the challenges in the pathologic identification of this neoplasm. Prompt and accurate identification of this tumor is becoming increasingly important, however, as we enter the era of therapeutic ALK inhibitors, which are currently undergoing study in several clinical trials. Here, we report a case of ALK-positive DLBCL in a 39-year-old male patient who presented with spontaneous tumor lysis syndrome. We review the clinical, morphologic, immunohistochemical, and molecular aspects of this case and of ALK-positive DLBCL in general, with the purpose of bringing to light the existence of this disease and its potential future therapy.
Assuntos
Biomarcadores Tumorais/genética , Linfoma Difuso de Grandes Células B/patologia , Obesidade/patologia , Receptores Proteína Tirosina Quinases/genética , Síndrome de Lise Tumoral/patologia , Adulto , Quinase do Linfoma Anaplásico , Antineoplásicos/uso terapêutico , Evolução Fatal , Humanos , Linfoma Difuso de Grandes Células B/complicações , Linfoma Difuso de Grandes Células B/tratamento farmacológico , Linfoma Difuso de Grandes Células B/genética , Masculino , Obesidade/complicações , Obesidade/tratamento farmacológico , Obesidade/genética , Síndrome de Lise Tumoral/complicações , Síndrome de Lise Tumoral/tratamento farmacológico , Síndrome de Lise Tumoral/genéticaRESUMO
Semaphorins are a large family of molecules involved in axonal guidance during the development of the nervous system and have been recently shown to have both angiogenic and anti-angiogenic properties. Specifically, semaphorin 7A (SEMA7A) has been reported to have a chemotactic activity in neurogenesis and to be an immune modulator through α1ß1integrins. SEMA7A has been shown to promote monocyte chemotaxis and induce them to produce proinflammatory mediators. In this study we explored the role of SEMA7A in a murine model of breast cancer. We show that SEMA7A is highly expressed by DA-3 murine mammary tumor cells in comparison to normal mammary cells (EpH4), and that peritoneal elicited macrophages from mammary tumor-bearing mice also express SEMA7A at higher levels compared to those derived from normal mice. We also show that murine macrophages treated with recombinant murine SEMA7A significantly increased their expression of proangiogenic molecule CXCL2/MIP-2. Gene silencing of SEMA7A in peritoneal elicited macrophages from DA-3 tumor-bearing mice resulted in decreased CXCL2/MIP-2 expression. Mice implanted with SEMA7A silenced tumor cells showed decreased angiogenesis in the tumors compared to the wild type tumors. Furthermore, peritoneal elicited macrophages from mice bearing SEMA7A-silenced tumors produce significantly (p < 0.01) lower levels of angiogenic proteins, such as CXCL2/MIP-2, CXCL1, and MMP-9, compared to those from control DA-3 mammary tumors. We postulate that SEMA7A in mammary carcinomas may skew monocytes into a pro-tumorigenic phenotype to support tumor growth. SEMA7A could prove to be valuable in establishing new research avenues toward unraveling important tumor-host immune interactions in breast cancer patients.
RESUMO
It is extremely rare for paragangliomas to be present in the brain. We present a 44-year-old man with a suprasellar-sellar paraganglioma encasing the internal carotid arteries. We review all such tumors reported in the literature and conclude that paraganglioma should be kept in the differential diagnosis of unusual suprasellar-sellar lesions.
Assuntos
Adenoma/diagnóstico , Neoplasias Encefálicas/diagnóstico , Diagnóstico Diferencial , Paraganglioma Extrassuprarrenal/diagnóstico , Neoplasias Hipofisárias/diagnóstico , Adulto , Artérias Carótidas/patologia , Humanos , MasculinoRESUMO
AIDS is an increasingly common diagnosis seen by neurologists and neurosurgeons alike. Although the more common brain lesions associated with AIDS are due to central nervous system lymphomas, toxoplasma encephalitis or progressive multifocal leukoencephalopathy, relatively recent clinical evidence has shown that AIDS-independent cerebral tumours can arise as well, albeit less commonly. Previous incidents have been reported with HIV and AIDS patients presenting with cerebral astrocytomas. To our knowledge, there has never been a report in the literature of a brainstem anaplastic glioma occurring in an AIDS or HIV patient. We report a 55-year-old patient with HIV and brainstem anaplastic glioma. Its presentation, diagnostic difficulty, scans, histology and subsequent treatment are discussed. We also review the relevant literature on gliomas in HIV/AIDS patients.
Assuntos
Neoplasias do Tronco Encefálico/diagnóstico , Glioma/diagnóstico , Infecções por HIV/complicações , Síndrome da Imunodeficiência Adquirida/complicações , Astrocitoma/complicações , Astrocitoma/diagnóstico , Neoplasias do Tronco Encefálico/complicações , Glioblastoma/complicações , Glioblastoma/diagnóstico , Glioma/complicações , Humanos , Masculino , Pessoa de Meia-IdadeRESUMO
Intestinal obstruction after liver transplant is a rare complication, with diverse clinical manifestations. Intestinal adhesion is the most common cause. However, internal hernia, abdominal wall hernia, and neoplasm are also reported. Intussusception is another rare cause of intestinal obstruction, which has been reported primarily in pediatric patients. Herein, we report a case of intestinal obstruction from intussusception in an adult liver transplant patient associated with post-transplant lymphoproliferative disorder.
RESUMO
Receipt of radical prostatectomy specimens in the histopathology laboratory is quite common in academic centers and community hospitals. Despite numerous processing protocols, there is not an accepted standard method of processing. There are potential disadvantages of total sampling of the prostate; however, other alternatives have not been proven to show significant advantages. We present a partial sampling method (alternate slice) and compare its results to the total embedding method. Consecutive radical prostatectomy specimens were selected to compare both histologic sampling methods. The primary method of sampling was total embedding. Subsequently, alternate slice sections from the anterior, middle, and posterior thirds of the gland were reviewed. Seminal vesicle, bladder neck, and margins were similarly evaluated in both methods. Total sampling resulted in an average of 30 blocks compared with 18 in the alternate slice method. Gleason correlation was 87.5%; extraprostatic extension correlation was 97.9%. There was complete correlation in margin status and perineural invasion. Pathologic staging correlation was 97.9%. In summary, this alternate slice method compares very favorably with the total embedding method.